October 16, 2025
Random News

QuettaWal News (کوئٹہ وال نیوز)

ھم ہیں آپکے ساتھ، ھم ہیں حق کے ساتھ۔

اسلام آباد میں پی ٹی آئی احتجاج کے دوران 4 رینجرز اہلکار شہید، فوج تعینات

Quettawalnews991 mins

اسلام آباد میں پاکستان تحریک انصاف (پی ٹی آئی) کے احتجاج کے دوران سری نگر ہائی وے پر شرپسندوں نے رینجرز کے 4 اہلکاروں کو گاڑی تلے کچل کر شہید کر دیا۔ اس افسوسناک واقعے میں پانچ افراد، جن میں پولیس اہلکار بھی شامل ہیں، زخمی ہو گئے ہیں۔ سکیورٹی ذرائع کے مطابق اس وقت تک 25 پولیس اہلکار شہید ہو چکے ہیں، جبکہ 100 سے زائد زخمی ہیں۔ واقعے کے فوراً بعد پاکستان فوج کو اسلام آباد کی سڑکوں پر تعینات کر دیا گیا ہے اور فوج کو آئین کے آرٹیکل 245 کے تحت فائرنگ کرنے کے احکامات دیے گئے ہیں۔ پی ٹی آئی نے 24 نومبر سے عمران خان کی رہائی کے لیے احتجاج شروع کر رکھا ہے۔

اسلام آباد میں پی ٹی آئی احتجاج کے دوران 4 رینجرز اہلکار شہید، فوج تعینات

99 thoughts on “اسلام آباد میں پی ٹی آئی احتجاج کے دوران 4 رینجرز اہلکار شہید، فوج تعینات”

  43. Anavar Results After 2 Weeks For Females

    **Yes – anabolic‑steroid use in women carries a real risk of side effects, many of which are quite specific to female physiology.**

    | Category | Typical side effect (in females) | Why it matters |
    |———-|———————————-|—————-|
    | **Virilization / “masculinizing” changes** | • Deepening of the voice
    • Facial or body hair growth (hirsutism)
    • Male‑pattern baldness or thinning of scalp hair
    • Enlarged clitoris (clitoromegaly)
    • Acne, oily skin | These changes can be permanent; they affect self‑image and sometimes fertility. |
    | **Hormonal / menstrual disturbances** | • Irregular periods or amenorrhea (missed periods)
    • Ovarian cysts
    • Early menopause (premature ovarian failure) | May lead to infertility or require hormonal therapy to maintain bone health. |
    | **Metabolic & cardiovascular risks** | • Elevated blood pressure, increased LDL cholesterol, reduced HDL
    • Higher risk of atherosclerosis and stroke
    • Liver enzyme elevations (especially with oral steroids) | Long‑term use can contribute to heart disease and liver complications. |
    | **Bone health** | • Osteoporosis due to chronic glucocorticoid exposure (if used for >3 months) | May necessitate calcium/vitamin D supplementation or bisphosphonates. |

    —

    ## 4. Practical Recommendations

    | Situation | Suggested Dose | Frequency | Duration | Monitoring / Precautions |
    |———–|—————-|————|———-|————————–|
    | **Mild–moderate acne** (facial, occasional breakouts) | **0.25 % tretinoin cream** applied nightly to affected areas. | Once nightly | 3‑6 months; may continue at reduced frequency if stable. | Educate on sun protection, moisturizers, avoid simultaneous use of other irritants (salicylic acid >1%, benzoyl peroxide >2.5%) until tolerated. |
    | **Severe acne with nodules or cysts** | **0.05–0.1 % tretinoin gel/cream** on affected skin and a small amount to the entire face if needed. | Once nightly | 6‑12 months; may adjust frequency based on tolerance. | Combine with oral antibiotics (e.g., doxycycline) or isotretinoin as per dermatology guidelines. |
    | **Adjunct therapy for post-acne scarring** | **0.05–0.1 % tretinoin** after scar treatment (laser, microneedling). | Once nightly | 6‑12 months; continue until improvement is seen. | Use in combination with other topical agents (e.g., retinoids). |

    ### Key Points for Clinicians

    – **Tolerability:** Most patients start with a lower concentration and gradually increase to avoid irritation.
    – **Adjunctive Care:** Sunscreen use, moisturizers, and gentle cleansers improve adherence.
    – **Patient Education:** Instruct on the delayed onset of benefit (4–8 weeks) and emphasize consistent application.

    —

    ## 6. Other FDA‑Approved Topical Treatments for Acne

    | Drug | Mechanism | Approved Indication | Typical Dosing |
    |——|———–|———————|—————-|
    | **Topical retinoids** (tretinoin, adapalene, tazarotene) | Modulate keratinization and anti‑inflammatory | Mild to moderate acne | 0.05–0.1 % daily |
    | **Azelaic acid** | Anti‑bacterial (C. acnes), anti‑inflammatory, keratolytic | Moderate acne; post‑inflammatory hyperpigmentation | 15–20 % twice daily |
    | **Benzoyl peroxide** | Oxidative kill of bacteria, reduces inflammation | Mild to moderate acne | 2.5–10 % once or twice daily |
    | **Topical antibiotics (clindamycin, erythromycin)** | Target bacterial proliferation | Mild to moderate acne | 1–3 % daily |
    | **Retinoids (tretinoin, adapalene)** | Promote cell turnover, prevent comedone formation | Mild to moderate acne | 0.05–0.1 % nightly |

    **Key Takeaway:** A rational approach begins with selecting a *single* topical agent that addresses the most prominent pathophysiologic abnormality (e.g., inflammation or follicular hyperkeratinization). If disease activity persists, subsequent agents are added sequentially rather than all at once.

    —

    ## 3. Practical Guidance for Adding Multiple Topicals

    ### 3.1. Sequential vs Concurrent Application

    | Approach | Pros | Cons |
    |———-|——|——|
    | **Sequential** (one agent first, add next after ≥4–6 weeks) | • Clear attribution of improvement or side‑effects
    • Reduced skin irritation risk
    • Easier patient compliance | • Longer time to reach optimal control |
    | **Concurrent** (multiple agents simultaneously from the start) | • Potentially faster disease clearance
    • Shorter overall treatment course | • Higher chance of cumulative irritation
    • Harder to identify culprit for adverse events |

    For most patients, a *sequential* strategy is safer. A typical sequence might be:

    1. **First line**: Topical corticosteroid (e.g., betamethasone dipropionate 0.05 % once daily) – short‑term use (2–4 weeks).
    2. **Second line**: Topical calcineurin inhibitor (tacrolimus 0.1 % ointment or pimecrolimus 1 % cream) – 2–3 months.
    3. **Third line**: If needed, low‑potency steroid again or consider phototherapy.

    ### Phototherapy Options

    If the rash is extensive or refractory to topical therapy:

    – **Excimer laser (308 nm)** or **UV‑B narrowband phototherapy** can be effective for large‑area dermatitis and may be more tolerable than systemic steroids.
    – A dermatology consult is recommended before initiating.

    —

    ## 4. Impact on COVID‑19 Vaccine Response

    ### Does Corticosteroid Use Impair Vaccine Immunogenicity?

    Short‑course, low‑dose corticosteroids are **not known to significantly blunt the antibody response** to COVID‑19 vaccines. Evidence from influenza and other vaccine studies shows that:

    – A single dose of 20 mg prednisone for 5 days does not markedly reduce seroconversion rates.
    – The effect is more pronounced only with higher cumulative doses (>7 days) or with doses >40 mg/day.

    ### Practical Guidance

    1. **Proceed with the COVID‑19 vaccine** as scheduled; do not delay due to the steroid taper.
    2. If possible, **time the vaccination during a period of minimal immunosuppression**, e.g., when the daily dose is ≤5 mg or after completion of the taper. This can be achieved by scheduling the vaccine on day 4–5 of the taper (day +7 from start), when the dose will be around 2–3 mg/day.
    3. **Document** the steroid dosing schedule and inform the vaccinating clinician, so they can consider timing accordingly.

    —

    ## Summary

    | Issue | Recommendation |
    |——-|—————-|
    | **Medication adherence & communication** | Follow physician‑prescribed taper; use calendar reminders; contact pharmacist for refill coordination; document doses in a medication log. |
    | **Missed or delayed appointment** | Reschedule as soon as possible; if urgent, call clinic; consider telehealth if available. |
    | **Timing of glucocorticoid taper relative to vaccination** | Aim to vaccinate when daily dose ≤ 3 mg prednisone (or equivalent); if not feasible, proceed with vaccination but note the dose and discuss with provider. |

    *These recommendations are based on current clinical guidelines for steroid tapering in inflammatory conditions and best practices for managing medication schedules and vaccinations.*

    References:

    https://www.valley.md/anavar-results-after-2-weeks

    Reply

  66. Ipamorelin is a synthetic growth hormone releasing peptide
    that has become popular among athletes and bodybuilders for its potential to increase natural growth hormone production, improve recovery times, and enhance muscle
    mass without some of the harsher side effects associated with
    other peptides or anabolic steroids. Despite its many reported benefits, it’s important to be aware of the possible side effects
    that can arise from using ipamorelin, whether administered as
    injections or through a nasal spray.

    Ipamorelin Side Effects: What You Need to Know

    The most common side effects linked to ipamorelin use are generally mild and often transient.
    Many users report experiencing injection site
    pain or irritation; redness, swelling, or slight itching can occur at the puncture point.
    Because ipamorelin stimulates growth hormone release, some individuals may experience water retention, leading to a feeling of bloatedness or
    temporary weight gain. Other frequent complaints
    include headaches, dizziness, and fatigue during the initial weeks of therapy
    as the body adjusts to increased hormone levels.
    In rare cases, users have noted mild tingling sensations in the
    extremities, which can be a sign of peripheral nerve irritation.

    Less common but more serious side effects are possible when ipamorelin is used at high
    doses or for prolonged periods. Excessive growth hormone production can lead to insulin resistance, which
    may increase blood sugar levels and potentially contribute to long‑term metabolic
    issues. Users with preexisting endocrine disorders should approach ipamorelin cautiously,
    as the peptide could exacerbate conditions such as acromegaly or pituitary tumors.

    Additionally, some people have reported an increased risk of
    developing joint pain or arthralgia after
    extended use, likely due to changes in cartilage metabolism induced by growth hormone.

    What Is Ipamorelin and How Does It Work?

    Ipamorelin is a pentapeptide that functions
    as a selective ghrelin receptor agonist. By binding
    to the growth hormone secretagogue receptors located on pituitary cells,
    it triggers the release of growth hormone into circulation. Unlike older peptides such
    as GHRP‑2 or GHRP‑6, ipamorelin’s structure allows for a more targeted stimulation with fewer side effects
    like excessive prolactin release or nausea. The peptide has a short half-life, typically lasting about 30 minutes to an hour in the bloodstream,
    which means its hormonal effects are relatively
    quick but also short-lived.

    Because growth hormone plays a crucial role in protein synthesis, tissue
    repair, and metabolic regulation, ipamorelin can indirectly
    influence muscle growth, fat loss, and overall vitality.
    Its selective action also helps preserve the
    natural balance of other hormones, making it an attractive option for those seeking
    to enhance performance without resorting to steroids or
    more invasive treatments.

    FAQs: Ipamorelin Side Effects

    How long do ipamorelin side effects usually last?

    Side effects such as injection site irritation or mild headaches typically resolve within a few days after stopping
    the peptide or adjusting the dosage. More systemic symptoms like water retention may persist for several weeks until hormone levels stabilize.

    Can ipamorelin cause weight gain?

    Because it increases growth hormone, ipamorelin can promote slight fluid
    retention and muscle mass gains. Users who notice unexplained weight increase should monitor their diet and hydration, as the weight is usually
    not due to fat accumulation but rather changes in water balance.

    Is it safe for people with diabetes?

    Growth hormone release can raise blood glucose levels.
    Individuals with diabetes should have their insulin or medication regimen monitored
    closely while using ipamorelin, and they may need dose adjustments or additional testing to avoid hyperglycemia.

    Are there any long‑term risks associated with ipamorelin use?

    Long-term data are limited, but prolonged excessive growth hormone exposure has been linked in some
    studies to increased cancer risk or metabolic disturbances.
    Regular medical check‑ups, including blood work and imaging when indicated,
    can help identify potential complications early.

    Can ipamorelin be combined safely with other peptides?

    When used alongside other growth hormone releasing peptides, the cumulative
    effect may amplify both benefits and side effects. It is advisable to consult a healthcare professional before
    combining ipamorelin with agents such as GHRP‑2 or sermorelin to avoid overstimulation of the pituitary.

    What precautions should be taken for injection site reactions?

    Use sterile needles, rotate injection sites regularly, and apply gentle pressure after each shot to reduce bruising or swelling.
    If a site becomes persistently painful or shows signs of infection, stop use and seek medical advice.

    Is there an age limit for ipamorelin usage?

    While ipamorelin is sometimes used in older adults to counteract the natural decline in growth hormone, its safety profile in children and adolescents has not
    been thoroughly studied. Pediatric use should only be considered under strict medical supervision.

    In summary, ipamorelin offers a promising route to enhance growth hormone levels with fewer adverse effects compared to other peptides
    or steroids. Nonetheless, users should remain vigilant about potential side
    effects ranging from mild injection site irritation to
    more serious metabolic disturbances. Regular monitoring, appropriate dosing,
    and consultation with healthcare professionals can help mitigate risks and
    ensure safer use of this peptide therapy.

    References:

    http://www.valley.md

    Reply

Leave a Reply to graph.org Cancel reply

Your email address will not be published. Required fields are marked *

Related News